The cannabis sector has undoubtedly become one of the world’s fastest-growing, ever-changing and most innovative sectors. The immense potential of cannabis has led to a new global industry that was worth around USD 13.4 billion in 2018 and is estimated to reach over USD 44 billion by 2024, according to research. But this is a complex new area, with laws and regulations varying across jurisdictions. As cannabis becomes more mainstream, there are unique challenges facing cannabis-related businesses (CRBs) as they enter unchartered territory.
Pearl Cohen’s Cannabis group has developed an unrivaled level of experience at the heart of the global cannabis industry, with Israel particularly becoming a lead exporter of innovative technological inventions in the cannabis field. Our wealth of industry knowledge, deep familiarity with the regulatory landscape and seamless cooperation with all our expert departments enable clients to confidently seize the business opportunities that lie before them.
In particular, we are a prime destination for the IPOs and shells’ mergers of cannabis companies, having engaged with most of the cannabis companies in Israel and taking many of our clients public over the last few years. Since many CRBs are entrepreneurial in nature, we also play a critical role in serving as outside general counsel, advising on mergers and acquisitions, investments and financing, capital markets and securities issues, regulatory compliance, intellectual property – patent and trademark protection and enforcement, litigation and other day-to-day operational advice.